Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02669901 · ClinicalTrials.gov registry record · NA
Naloxone Auto-injector as a Universal Precaution for Patients With Opioid Use Disorder
A NA study, sponsored by University of New Mexico.
- Completed
- Registry status
- NA
- Development phase
- 395
- Enrollment target
NCT02669901 is a NA study that has completed, run by University of New Mexico. The registered enrollment target is 395 participants.
The verdict
NCT02669901, a NA study, has completed, sponsored by University of New Mexico.
- COMPLETED
- Registry status
- NA
- Development phase
- 395 participants
- Enrollment target
Study Summary
The purpose of this pilot-study is to to distribute naloxone auto-injector in a "Universal Precaution" manner to patients with opioid substance use disorder. The objectives are to decrease the number of fatal and nonfatal overdose deaths, to examine and understand the risk factors for serious opioid toxicity and overdose, and to evaluate the unintentional opioid overdose risk utilizing an evidence-based screening questionnaire.
Interventions
- BEHAVIORAL Naloxone Auto-Injector
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 395 participants |
| Start Date | 2016-04-04 |
| Est. Completion | 2020-08-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02669901
The ClinicalTrials.gov registry entry for NCT02669901 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 395 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of New Mexico, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Naloxone Auto-Injector is the first listed.
NCT02669901 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02669901 about?
NCT02669901 is a clinical study titled "Naloxone Auto-injector as a Universal Precaution for Patients With Opioid Use Disorder". The purpose of this pilot-study is to to distribute naloxone auto-injector in a "Universal Precaution" manner to patients with opioid substance use disorder. The objectives are to decrease the number of fatal and nonfatal overdose deaths, to examine and understand the risk factors for serious opioid...
What is the current status of trial NCT02669901?
This trial is currently completed. It is a NA study. The enrollment target is 395 participants. The study started on 2016-04-04. Estimated completion is 2020-08-20.
What interventions are being tested in trial NCT02669901?
The interventions under investigation include: Naloxone Auto-Injector (BEHAVIORAL).
Who is sponsoring clinical trial NCT02669901?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.